Anthem Biosciences is India’s fastest-growing biotechnology and contract research company. Since the IPO in the year 2025, the company’s shares have captured powerful interest from investors as well as analysts. Its powerful business approach, global client, and focus on upgraded drug explorative technology have attracted significant attention from retail and institutional investors. In this blog, we will guide you through Anthem Biosciences’ share price, history, target, listing, strengths and weaknesses, and much more.
Anthem Biosciences
Anthem Biosciences is a contract research, development, and manufacturing organisation (CRDMO) located in Bangalore, India. The company gives end-to-end exploration, development, and manufacturing abilities for small molecules as well as biological compounds, guiding world pharmaceutical and biotechnological forms with research and services.
The company was founded in the year 2006 and has extended its technological platforms, containing RNA interference (RNAi), antibody-drug conjugates (ADCs), peptides, lipids, and oligonucleotides. It also generates fermentation associated with active pharmaceutical ingredients (APIs).
| Metric | Details |
| Founded | 2006 |
| Headquarters | Bengaluru, India |
| Stage | Publicly listed |
| Revenue (FY) | Rs 1,845 Cr |
| Profit (FY) | Rs 451 Cr |
| Employees | 1,000+ |
Anthem Biosciences Share Price Listing
| Particulars | Details |
| Company Name | Anthem Biosciences Ltd |
| IPO Opening Date | July 2025 |
| IPO Price Band | Rs 540 – Rs 570 per share |
| Issue Type | Mainboard IPO |
| Listing Exchange | NSE & BSE |
| IPO Issue Size | Approx. Rs 3,395 crore |
| Listing Date | 21 July 2025 |
| Listing Price (NSE) | Around Rs 723 |
| Listing Price (BSE) | Around Rs723 |
| Listing Gain | Approx. 27% over IPO price |
| Investor Response | Strong demand from retail and institutional investors |
| Market Sentiment on Listing | Positive |
Anthem Biosciences Share Price History
Since the listing of July 2025, the Anthem Biosciences stock has showcased positive motion depicting market sentiments, earnings outcomes, and sector performance.
Now, let’s see the overview of the price:
- Anthem’s shares began trading above the IPO price and burst importantly in the months immediately after the listing with gianing 46% since listing by late 2025, following powerful financial outcomes.
- The 52-week high for Anthem Biosciences shares has been around Rs 873.50, while the 52-week low approx Rs 620.
- In early January 2026, the price was trading between Rs 629 to Rs 645.
Given below is the recent price history from December 2025 to January 2026. Let’s see in detail:
| Date | Approx Price (Rs) |
| January 09, 2026 | Rs 629–Rs 630 |
| January 08, 2026 | Rs 645 |
| December 23, 2025 | Rs 669–Rs 681 |
| December 15, 2025 | Rs 699 |
Anthem Biosciences Share Price (2026)
As of January 2026, the Anthem Biosciences share price is given below:
| Metric | Value (Approx.) |
| Share Price (Early Jan 2026) | Around Rs 638-Rs 654 range |
| Latest Reported Price (Approx.) | Around the Rs 615-Rs 648 range |
| 52-Week High (2025–26) | Rs 873.25–Rs 873.50 |
| 52-Week Low (2025–26) | Rs 620 |
| Market Capitalisation | Rs 35,000–Rs 36,700 crore (varies by date) |
| Trading Status | Midcap stock |
Factors Impacting Anthem Biosciences Share Price
Given below are some of the factors that influence Anthem Biosciences’ share price, presented in detail:
- Company Financial Performance: It is the most crucial factor impacting the share price and how well the company performs in terms of finance. If the company’s revenue is growing, enhancing profits and positive cash flow, then the price will go up. On the opposite side, slow earnings lead to a lower price.
- Biotechnology and CRDMO Growth: Anthem Biosciences functions in the biotechnology and CRDMO sectors. Increasing demand globally for the research outsourcing advantages the companies such as Anthem Biosciences. The pharmaceutical companies mostly prefer outsourcing R&D and manufacturing to limit costs and development.
- Client Relationships: The contracts that are long-term and with repeated clients show future revenue which is stable. The expansion of the client base into new geographical areas increases investors’ confidence. Also, any important loss of a client or delay can influence the share price negatively.
- Research and Innovation: Anthem Bioseciences’ emphasis on upgraded drug discovery platforms and creative technologies. Investing in research leads to higher growth. However, research and development require high spending, which might affect profits that are short-term profits.
- IPO Valuation and Market Expectations: As we know that Anthem Biosciences is a listed company, so market expectations stay high. If the company increases its expectations, the share price will go up. On the other hand, if growth slows, then the investors may react fast, and the price may fall.
- Market Conditions: The total market trends also impact the share price of Anthem Biosciences. If there are positive markets, then its stock will perform best. Also, if the market conditions are uncertain, then the stocks might fall.
Anthem Biosciences Share Price Target
| Category | Details |
| Current Trading Range (2026) | Rs 620 – Rs 660 |
| Average 12-Month Price Target | Rs 765 |
| Lowest Analyst Target | Rs 740 |
| Highest Analyst Target | Rs 798 |
| Expected Upside Potential | 18% – 22% |
| Analyst Recommendation | Buy / Positive |
| Investment Time Frame | 12 months |
| Outlook | Bullish with moderate volatility |
Strengths and Weaknesses: Anthem Biosciences Share Price
Given below are some of the strengths and risks while investing in the Anthem Biosciences share price that you should know in detail:
| Strengths | Weaknesses |
| Strong listing performance with healthy gains after IPO | Share price volatility is common in biotech stocks |
| Operates in the high-growth CRDMO and biotechnology sector | Valuation remains relatively premium compared to peers |
| Consistent revenue growth supported by global clients | High dependence on global pharmaceutical demand |
| Advanced capabilities in drug discovery and manufacturing | Sensitive to regulatory and compliance changes |
| Positive analyst outlook and favourable share price targets | Limited public trading history as a recently listed company |
| Strong institutional and retail investor interest | Market sentiment can quickly impact price movements |
| Long-term growth potential due to increasing R&D outsourcing | Earnings growth expectations are already priced into the stock |
Conclusion
The Anthem Biosciences share price is impacted by lots of powerful business principles, industry growth, creation, capabilities and huge market trends. While short-term fluctuation is normal, particularly for the newly listed biotechnology stock. The long-term motion depends on the company’s capability to provide continuous growth and implement the strategies.
Disclaimer: The above information is only for informational purposes, so not be regarded as financial, investment, or legal advice. The prices may change as per the market. Readers of this blog are advised to always consult a financial advisor before making any investment. The blog and author do not guarantee the accuracy.
